Prospector Partners LLC Sells 402,495 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Prospector Partners LLC lessened its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 59.6% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 272,475 shares of the medical instruments supplier's stock after selling 402,495 shares during the quarter. Prospector Partners LLC owned about 0.14% of DENTSPLY SIRONA worth $7,373,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Advisors Asset Management Inc. increased its holdings in shares of DENTSPLY SIRONA by 99.3% in the first quarter. Advisors Asset Management Inc. now owns 14,548 shares of the medical instruments supplier's stock worth $483,000 after purchasing an additional 7,248 shares during the period. Tidal Investments LLC raised its holdings in shares of DENTSPLY SIRONA by 292.4% in the 1st quarter. Tidal Investments LLC now owns 24,149 shares of the medical instruments supplier's stock valued at $802,000 after acquiring an additional 17,995 shares in the last quarter. Comerica Bank raised its holdings in shares of DENTSPLY SIRONA by 2.9% in the 1st quarter. Comerica Bank now owns 42,568 shares of the medical instruments supplier's stock valued at $1,413,000 after acquiring an additional 1,205 shares in the last quarter. Virtu Financial LLC bought a new stake in shares of DENTSPLY SIRONA during the 1st quarter valued at about $1,027,000. Finally, Cetera Advisors LLC grew its holdings in shares of DENTSPLY SIRONA by 18.6% during the first quarter. Cetera Advisors LLC now owns 17,052 shares of the medical instruments supplier's stock worth $566,000 after purchasing an additional 2,675 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on XRAY shares. Needham & Company LLC dropped their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating for the company in a research report on Friday, October 25th. StockNews.com downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Tuesday, November 19th. Leerink Partners cut DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a research note on Thursday, November 7th. Robert W. Baird dropped their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating for the company in a research note on Friday, November 8th. Finally, Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research note on Thursday, November 7th. Seven research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $29.50.

DENTSPLY SIRONA Stock Down 1.7 %

DENTSPLY SIRONA stock traded down $0.33 on Tuesday, hitting $19.19. 1,926,668 shares of the stock traded hands, compared to its average volume of 3,132,023. The business's fifty day simple moving average is $23.12 and its 200 day simple moving average is $24.99. The firm has a market cap of $3.81 billion, a P/E ratio of -9.26, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million for the quarter, compared to analysts' expectations of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business's revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.49 EPS. As a group, sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.